Some studies have shown that high levels of soluble PD-1 and PD-L1 are associated with worse clinical outcomes in several types of tumours [25], [26]; moreover, researchers have speculated that the expression of these markers in peripheral blood reflects the immune environment and have shown them to be highly correlated with malignant neoplasm behaviour [7]. Here, CD274 is linked to neoplasm.